Thank you to Amanda Bruno and our friends at the City of Tucson for featuring Reglagene.

Hot off the press! Our very own Chief Scientific Officer Dr. Laurence Hurley honored in a special issue.

Congratulations to Reglagene's Chief Scientific Officer Dr. Laurence Hurley for the granting of FDA Fast Track status for Pidnarulex, the only DNA quadruplex-targeting therapy that is active in human clinical trials.

Congratulations to our Scientific Advisor Dr. Matthew Marx, co-inventor of the clinical KRAS G12C inhibitor adagrasib, which was recently voted #2 drug of the year.

It was a great way to celebrate International Women's Day as Dr. Teri Suzuki presented at the Eureka Institute Conference.

Proud to be one of 12 out of 98 companies given the opportunity to share how we are fighting cancer safely.

Reglagene's Director of Operations Michael Abrahamson presents at Destination Startup.

We’re honored to be recognized as an up-and-comer in the life science arena.

Look forward to attending Destination Startup in Denver, Colorado next month.